Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2026-02-25 @ 6:43 PM
Study NCT ID:
NCT05918133
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-11
First Post:
2023-06-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
Sponsor:
Biotheus Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PM8002-B004C-TNBC-R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None